Assessment of the Results of Neurafill Volume Filler Injections to Correction Nasolabial Folds
Phase 2
- Conditions
- Skin aging.
- Registration Number
- IRCT20220723055530N2
- Lead Sponsor
- Azar mehr teb parsian
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
25 -60 Years old men and women with moderate to severe nasolabial folds
Signing the informed consent form
Exclusion Criteria
Having History of a cosmetic procedure in the lower 2/3 of the face during the last three months
Presence of active infection, inflammation, unhealed old wound, and skin lesions in the NLF area
HavingPrevious allergy to Hyaluronic Acid or Lidocaine
History of autoimmune or immune deficiency diseases
Individuals prone to hypertrophic scar formation
Pregnancy or breastfeeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of nasolabial folds. Timepoint: Before intervention, immediately after that, 2 weeks, and 3 months later. Method of measurement: Five-point photonumeric Allergan scale.
- Secondary Outcome Measures
Name Time Method Area, depth, and volume of nasolabial folds. Timepoint: Before the intervention, immediately after that, 2 weeks, and 3 months later. Method of measurement: Visioface camera.